Literature DB >> 2240857

The inactivation of antithrombin III by serum elastase in patients with surgical infections.

J R Cohen1, I Sarfati, E Birnbaum, T Benacquista, L Wise.   

Abstract

The relationship between serum elastase and antithrombin III was determined in septic surgical patients as a possible mechanism for intravascular thrombosis and hypercoagulability during sepsis. Eighteen patients with surgical infections and elevated white blood cell counts had their blood assayed daily for white blood cell count, serum elastase, and antithrombin III, until the patient's white blood cell count returned to normal. Antithrombin III was significantly lower (0.87%) when elastase was above the normal range (greater than 14.2 micrograms/ml). Elastase was significantly higher (30.6 micrograms/ml), when antithrombin III was less than normal. These data indicate that elevated serum elastase is associated with a significant reduction in circulating antithrombin III. Stimuli that increase serum elastase, i.e. surgery, trauma, or sepsis may promote intravascular thrombosis by the inhibition of antithrombin III at the blood-endothelial cell interface.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2240857

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  5 in total

1.  Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.

Authors:  Ming Bai; Meilan Zhou; Lijie He; Feng Ma; Yangping Li; Yan Yu; Pengbo Wang; Li Li; Rui Jing; Lijuan Zhao; Shiren Sun
Journal:  Intensive Care Med       Date:  2015-12       Impact factor: 17.440

2.  Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis.

Authors:  Ravi S Keshari; Robert Silasi; Narcis I Popescu; Constantin Georgescu; Hala Chaaban; Cristina Lupu; Owen J T McCarty; Charles T Esmon; Florea Lupu
Journal:  J Thromb Haemost       Date:  2019-10-16       Impact factor: 5.824

Review 3.  Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?

Authors:  Heleen M Oudemans-van Straaten; John A Kellum; Rinaldo Bellomo
Journal:  Crit Care       Date:  2011-01-24       Impact factor: 9.097

4.  Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?

Authors:  Johannes N Hoffmann; Kerstin Schick
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

5.  Evaluating continuous blood coagulopathy in assessing the severity of acute colitis in Thoroughbred racehorses.

Authors:  Motoi Nomura; Fumiaki Mizobe; Tomohiro Kato; Taisuke Kuroda; Shuntaro Urayama; Masanori Muranaka
Journal:  J Equine Sci       Date:  2018-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.